ArticlePharmacoEconomics2024

Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition.

Daniel Tobias Michaeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.